证券记录 · 已归档季度
ROIV
Roivant Sciences Ltd. · Healthcare · Biotechnology
16被追踪持有人
+1Δ持有人
211.12M持有股份
$2.38B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +6.7% ·
股份流向 -6.0% ·
净新建仓位 +6.2%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +11 | 408.23M | $14.45B | +15 | −3 |
| Q1 2026 | 122 | +5 | 384.63M | $10.65B | +13 | −9 |
| Q4 2025 | 117 | +1 | 374.22M | $8.12B | +3 | −1 |
| Q3 2025 | 19 | +1 | 262.46M | $3.97B | +1 | −1 |
| Q2 2025 | 16 | +1 | 211.12M | $2.38B | +1 | — |
| Q1 2025 | 12 | +1 | 89.39M | $901.93M | +2 | −1 |
| Q4 2024 | 11 | -2 | 96.86M | $1.15B | — | −2 |
| Q3 2024 | 12 | -1 | 85.45M | $986.08M | +1 | −2 |
| Q2 2024 | 13 | — | 92.40M | $976.70M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 55.51M | — | $625.59M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 55.51M | — | $625.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 55.51M | — | $625.59M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 55.51M | — | $625.59M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 55.51M | — | $625.59M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 40.32M | — | $454.36M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 39.33M | — | $443.21M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 39.33M | — | $443.21M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (被动) | 39.33M | — | $443.21M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (被动) | 39.33M | — | $443.21M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (被动) | 39.33M | — | $443.21M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Viking Global Investors ✦ | 34.24M | -25.6% | $385.86M | 1.1% | ▼ Trim | 5 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (被动) | 19.77M | +4.8% | $222.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Geode Capital Management ✦ (被动) | 7.75M | -2.7% | $87.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Geode Capital Management ✦ (被动) | 7.75M | -2.7% | $87.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Greenlight Capital (DME Capital) ✦ | 4.55M | -16.4% | $51.29M | 2.2% | ▼ Trim | 5 | SEC ↗ |
| 31 | Greenlight Capital (DME Capital) ✦ | 4.55M | -16.4% | $51.29M | 2.2% | ▼ Trim | 5 | SEC ↗ |
| 32 | Greenlight Capital (DME Capital) ✦ | 4.55M | -16.4% | $51.29M | 2.2% | ▼ Trim | 5 | SEC ↗ |
| 33 | Point72 Asset Management ✦ | 2.95M | +380.4% | $33.26M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Adage Capital Partners ✦ | 2.08M | -45.5% | $23.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 1.47M | +463.6% | $16.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 1.47M | +463.6% | $16.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Millennium Management ✦ | 965.97K | +493.5% | $10.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | Marshall Wace ✦ | 955.15K | +251.4% | $10.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Marshall Wace ✦ | 955.15K | +251.4% | $10.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Norges Bank ✦ (被动) | 616.87K | -86.5% | $6.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 492.13K | -63.6% | $5.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | D. E. Shaw & Co. ✦ | 83.68K | 新增 | $943,119 | 0.0% | New | 1 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 83.68K | 新增 | $943,119 | 0.0% | New | 1 | SEC ↗ |
| 44 | Gotham Asset Management ✦ | 39.15K | +0.3% | $441,209 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $943,119 | 0.0% |
| D. E. Shaw & Co. | $943,119 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 436 持有人, 528.48M 股份, $14.35B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 21
Sukhatme Mayukh
Officer, Director · 144.76K 股 · $5.28M
Aug 20
Sukhatme Mayukh
Officer, Director · 17.52K 股 · $653,459
Aug 19
Sukhatme Mayukh
Officer, Director · 172.90K 股 · $6.43M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — MORGAN STANLEY
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据